Special 301 Report expresses concern over weak IPR laws, to conduct reviews.
Adverse IPR report expected this week;Poor labelling could take fight to WTO
Delegation visit ahead of patent law report.
The council resisted intense pressure from the powerful manufacturing, pharma and other trade lobbies that have urged the Obama administration to enact punitive measures against India for a laundry list of alleged intellectual property and patent violations.
A Priority Foreign Country is a status reserved for those nations that are the most egregious violators of intellectual property rights and have the most negative impact on US competitiveness abroad.
A certain segment of the US pharma industry have become vocal about Indian policies on domestic content requirements and IPR.
India is not so keen to co-operate with the US on IPR related probe.
Even as India continues on the priority watch list of the Office of the US Trade Representative, strong voices from Washington, DC, have spoken out in favour of India, reports Aziz Haniffa/Rediff.com.
The unilateral pressure by US administration on India, at the behest of US Business Associations lobby through US International Trade Commission investigations and request to USTR to enlist India under Priority Foreign Country under Special 301 review, lacks legitimacy under WTO framework, the signatories to the letter said.
India and the US should not get into any lengthy investigations for business related concerns.